Prothena Corporation plc Logo

Email this page: News Release

Prothena's NEOD001 Protein Immunotherapy Clinical Data Highlighted in Oral Presentation at the 20th Congress of the European Hematology Association

For security reasons, registration is required before you can use this feature.
* Indicates required field